Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substancesText with EEA relevance

Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances OJ 196, 16.8.1967, p. 1. , and in particular Article 28 thereof, Whereas: (1) Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical. (2) Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances. (3) Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances. (4) Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses. (5) Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement. (6) The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties.

(7) As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances. (8) The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive. (9) The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations, HAS ADOPTED THIS DIRECTIVE:

Article 1

Directive 67/548/EEC is amended as follows. Annex I is amended as follows: (a) the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex; (b) the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC; (c) the entries set out in Annex 1C to this Directive are deleted.

Article 2

Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 June 2009 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive. When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made. Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.

Article 3

This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Article 4

This Directive is addressed to the Member States. Done at Brussels, 15 January 2009. For the Commission Stavros Dimas Member of the Commission

Annex

ANNEX 1A Index NoChemical nameNotes related to substancesEC NoCAS NoClassificationLabellingConcentration LimitsNotes related to preparations001-002-00-4aluminium lithium hydride240-877-916853-85-3 F; R15 C; R35 F; C R: 15-35 S: (1/2-)7/8-26-36/37/39-43-45 005-006-00-7dibutyltin hydrogen borateE401-040-575113-37-0 Muta. Cat. 3; R68 Repr. Cat. 2; R60-61 T; R48/25 Xn; R21/22

Xi; R41 R43 N; R50-53 T; N R: 60-61-21/22-41-43-48/25-68-50/53 S: 53-45-60-61 006-007-00-5salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this AnnexA—— T+; R26/27/28 R32 N; R50-53 T+; N R: 26/27/28-32-50/53 S: (1/2-)7-28-29-45-60-61 006-015-00-9 diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea 206-354-4330-54-1 Carc. Cat. 3; R40 Xn; R22-48/22 N; R50-53 Xn; N R: 22-40-48/22-50/53 S: (2-)13-36/37-46-60-61 C ≥ 25 %: Xn, N; R22-40-48/22-50/53 10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53 2,5 % ≤ C < 10 %: Xn, N; R40-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 006-076-00-1 mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt —8018-01-7 Repr. Cat. 3; R63 R43 N; R50 Xn; N R: 43-63-50 S: (2-)36/37-46-61 C ≥ 5 %: Xn, N; R43-63-50 2,5 ≤ C < 5 %: Xi, N; R43-50 1 % ≤ C < 2,5 %: Xi; R43 006-077-00-7 maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) 235-654-812427-38-2 Repr. Cat. 3; R63 Xn; R20 Xi; R36 R43 N; R50-53 Xn; N R: 20-36-43-63-50/53 S: (2-)36/37-46-60-61 C ≥ 25 %: Xn, N; R20-36-43-63-50/53 20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53 5 % ≤ C < 20 %: Xn, N; R43-63-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 006-084-00-5 carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate 259-565-955285-14-8 T+; R26 T; R25 R43 N; R50-53 T+; N R: 25-26-43-50/53 S: (1/2-)28-36/37-38-45-63-60-61 006-088-00-7 benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate —82560-54-1 Repr. Cat. 3; R62 T; R23 Xn; R22 N; R50-53 T; N R: 22-23-62-50/53 S: (1/2-)36/37-45-60-61 007-002-00-0 nitrogen dioxide; [1] dinitrogen tetraoxide [2] 233-272-6 [1] 234-126-4 [2] 10102-44-0 [1] 10544-72-6 [2] O; R8 T+; R26 C; R34 O; T+ R: 8-26-34 S: (1/2-)9-26-28-36/37/39-45 C ≥ 10 %: T+; R26-34 5 % ≤ C < 10 %: T; R23-34 1 % ≤ C < 5 %: T; R23-36/37/38 0,5 % ≤ C < 1 %: Xn; R20-36/37/38 0,1 % ≤ C < 0,5 %: Xn; R20 5015-041-00-X malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate; [containing ≤ 0,03 % isomalathion] 204-497-7121-75-5 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)24-37-46-60-61 C ≥ 25 %: Xn, N; R22-43-50/53 1 % ≤ C < 25 %: Xi, N; R43-50/53 0,025 % ≤ C < 1 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 015-100-00-X phoxim (ISO); α-(diethoxyphosphinothioylimino) phenylacetonitrile 238-887-314816-18-3 Repr. Cat. 3; R62 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-62-50/53 S: (2-)36/37-46-60-61 C ≥ 25 %: Xn, N; R22-43-62-50/53 5 % ≤ C < 25 %: Xn, N; R43-62-50/53 1 % ≤ C < 5 %: Xi, N; R43-50/53 0,025 % ≤ C < 1 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 015-102-00-0tris(2-chloroethyl)phosphateE204-118-5115-96-8 Carc. Cat. 3; R40

Repr. Cat. 2; R60 Xn; R22 N; R51-53 T; N R: 60-22-40-51/53 S: 53-45-61 015-155-00-X glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate E278-636-577182-82-2 Repr. Cat. 2; R60 Repr. Cat. 3; R63 Xn; R20/21/22-48/20/22 T R: 60-20/21/22-48/20/22-63 S: 53-45 016-009-00-8 disodium sulfide; sodium sulfide 215-211-51313-82-2 T; R24 Xn; R22 C; R34 R31 N; R50 T; C; N R: 22-24-31-34-50 S: (1/2-)26-36/37/39-45-61 017-009-00-0 ammonium perchlorate; [containing ≥ 80 % of 0-30 μm particles] T232-235-17790-98-9 E; R3 O; R9 E R: 3-9 S: (2-)14-16-36/37 024-004-00-7sodium dichromateE234-190-310588-01-9 O; R8 Carc. Cat. 2; R45 Muta. Cat. 2; R46 Repr. Cat. 2; R60-61 T+; R26 T; R25-48/23 Xn; R21 C; R34 R42/43 N; R50-53 O; T+; N R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53 S: 53-45-60-61 C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53 10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53 7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53 5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53 3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53 2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53 1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53 0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53 0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53 0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43 0,1 % ≤ C < 0,2 %: T; R45-46-20 3027-002-00-4cobalt oxide215-154-61307-96-6 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 C ≥ 25 %: Xn, N; R22-43-50/53 2,5 % ≤ C < 25 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 027-003-00-Xcobalt sulfide215-273-31317-42-6 R43 N; R50-53 Xi; N R: 43-50/53 S: (2-)24-37-60-61 C ≥ 2,5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 028-003-00-2 nickel monoxide; [1] nickel oxide; [2] bunsenite [3] E 215-215-7 [1] 234-323-5 [2]

• [3] 1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] Carc. Cat. 1; R49 T; R48/23 R43 R53 T R: 49-43-48/23-53 S: 53-45-61 028-004-00-8nickel dioxideE234-823-312035-36-8 Carc. Cat. 1; R49 T; R48/23 R43 R53 T R: 49-43-48/23-53 S: 53-45-61 028-005-00-3dinickel trioxideE215-217-81314-06-3 Carc. Cat. 1; R49 T; R48/23 R43 R53 T R: 49-43-48/23-53 S: 53-45-61 028-006-00-9 nickel (II) sulfide; [1] nickel sulfide; [2] millerite [3] E 240-841-2 [1] 234-349-7 [2]
• [3] 16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] Carc. Cat. 1; R49 Muta. Cat. 3; R68 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-68-50/53 S: 53-45-60-61 028-007-00-4 trinickel disulfide; nickel subsulfide; [1] heazlewoodite [2] E 234-829-6 [1]
• [2] 12035-72-2 [1] 12035-71-1 [2] Carc. Cat. 1; R49 Muta. Cat. 3; R68 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-68-50/53 S: 53-45-60-61 028-008-00-X nickel dihydroxide; [1] nickel hydroxide [2] E 235-008-5 [1] 234-348-1 [2] 12054-48-7 [1] 11113-74-9 [2] Carc. Cat. 1; R49 Repr. Cat. 2; R61 Muta. Cat. 3; R68 T; R48/23 Xn; R20/22

Xi; R38 R42/43 N; R50-53 T; N R: 49-61-20/22-38-42/43-48/23-68-50/53 S: 53-45-60-61 029-013-00-Xtrisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)407-580-8130201-51-3Xi; R41 Xi R: 41 S: (2-)26-39 033-005-00-1arsenic acid and its salts with the exception of those specified elsewhere in this AnnexAE—— Carc. Cat. 1; R45 T; R23/25 N; R50-53 T; N R: 45-23/25-50/53 S: 53-45-60-61 034-002-00-8selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this AnnexA—— T; R23/25 R33 N; R50-53 T; N R: 23/25-33-50/53 S: (1/2-)20/21-28-45-60-61 047-001-00-2silver nitrate231-853-97761-88-8 O; R8 C; R34 N; R50-53 O; C; N R: 8-34-50/53 S: (1/2-)26-36/37/39-45-60-61 050-002-00-0 cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide 236-049-113121-70-5 Xn; R20/21/22 N; R50-53 Xn; N R: 20/21/22-50/53 S: (2-)13-60-61 C ≥ 25 %: Xn, N; R20/21/22-50/53 0,025 % ≤ C < 25 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 050-003-00-6 fentin acetate (ISO); triphenyltin acetate 212-984-0900-95-8 Carc. Cat. 3; R40 Repr. Cat. 3; R63 T+; R26 T; R24/25-48/23 Xi; R37/38-41 N; R50-53 T+; N R: 24/25-26-37/38-40-41-48/23-63-50/53 S: (1/2-)26-28-36/37/39-45-60-61 C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53 20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53 10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53 7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53 5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53 3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53 2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53 1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53 0,25 % ≤ C < 1 %: Xn, N; R20-51/53 0,1 % ≤ C < 0,25 %: Xn; R20-52/53 0,025 % ≤ C < 0,1 %: R52/53 050-004-00-1 fentin hydroxide (ISO); triphenyltin hydroxide 200-990-676-87-9 Carc. Cat. 3; R40 Repr. Cat. 3; R63 T+; R26 T; R24/25-48/23 Xi; R37/38-41 N; R50-53 T+; N R: 24/25-26-37/38-40-41-48/23-63-50/53 S: (1/2-)26-28-36/37/39-45-60-61 C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53 20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53 10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53 7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53 5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53 3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53 2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53 1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53 0,25 % ≤ C < 1 %: Xn, N; R20-51/53 0,1 % ≤ C < 0,25 %: Xn; R20-52/53 0,025 % ≤ C < 0,1 %: R52/53 050-008-00-3tributyltin compounds, with the exception of those specified elsewhere in this AnnexA—— T; R25-48/23/25 Xn; R21 Xi; R36/38 N; R50-53 T; N R: 21-25-36/38-48/23/25-50/53 S: (1/2-)36/37/39-45-60-61 C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53 1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53 0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53 0,025 % C < 0,25 %: R52/53 1050-011-00-Xtriphenyltin compounds, with the exception of those specified elsewhere in this AnnexA——

T; R23/24/25 N; R50-53 T; N R: 23/24/25-50/53 S: (1/2-)26-27-28-45-60-61 C ≥ 1 %: T, N; R23/24/25-50/53 0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 1050-018-00-8tin(II) methanesulphonate401-640-753408-94-9 C; R34 Xn; R22 R43 N; R51-53 C; N R: 22-34-43-51/53 S: (1/2-)22-26-36/37/39-45-61 053-003-00-4iodoxybenzene—696-33-3E; R2 E R: 2 S: (2-)35 053-004-00-Xcalcium iodoxybenzoateC——E; R2 E R: 2 S: (2-)35 080-001-00-0mercuryE231-106-77439-97-6 Repr. Cat. 2; R61 T+; R26 T; R48/23 N; R50-53 T+; N R: 61-26-48/23-50/53 S: 53-45-60-61 080-010-00-X mercury dichloride; mercuric chloride 231-299-87487-94-7 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T+; R28 T; R48/24/25 C; R34 N; R50-53 T+; N R: 28-34-48/24/25-62-68-50/53 S: (1/2-)26-36/37/39-45-60-61 092-002-00-3uranium compounds with the exception of those specified elsewhere in this AnnexA—— T+; R26/28 R33 N; R51-53 T+; N R: 26/28-33-51/53 S: (1/2-)20/21-45-61 601-065-00-3 A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane); (1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane) 416-930-9— Xi; R38 N; R51-53 Xi; N R: 38-51/53 S: (2-)36/37-61 602-007-00-X bromoform; tribromomethane 200-854-675-25-2 T; R23 Xn; R22 Xi; R36/38 N; R51-53 T; N R: 22-23-36/38-51/53 S: (1/2-)28-45-63-61 602-030-00-5 1,3-dichloropropene; [1] (Z)-1,3-dichloropropene [2] C D 208-826-5 [1] 233-195-8 [2] 542-75-6 [1] 10061-01-5 [2] R10 T; R24/25 Xn; R20-65 Xi; R36/37/38 R43 N; R50-53 T; N R: 10-20-24/25-36/37/38-43-65-50/53 S: (1/2-)36/37-45-60-61 602-054-00-6 3-iodpropene; allyl iodide 209-130-4556-56-9 F; R11 C; R34 F; C R: 11-34 S: (1/2-)7-16-26-45 603-005-00-1 2-methylpropan-2-ol; tert-butyl alcohol 200-889-775-65-0 F; R11 Xn; R20 Xi; R36/37 F; Xn R: 11-20-36/37 S: (2-)9-16-46 603-018-00-2furfuryl alcohol202-626-198-00-0 Carc. Cat. 3; R40 T; R23 Xn; R21/22-48/20 Xi; R36/37 T R: 21/22-23-36/37-40-48/20 S: (1/2-)36/37-45-63 603-023-00-X ethylene oxide; oxirane E200-849-975-21-8 F+; R12 R6 Carc. Cat. 2; R45 Muta. Cat. 2; R46 T; R23 Xi; R36/37/38 F+; T R: 45-46-6-12-23-36/37/38 S: 53-45 603-029-00-2bis(2-chloroethyl) ether203-870-1111-44-4 Carc. Cat. 3; R40 T+; R26/27/28 T+ R: 26/27/28-40 S: (1/2-)7/9-27-28-36/37-45 C ≥ 7 %: T+; R26/27/28-40 1 % ≤ C < 7 %: T; R23/24/25-40 0,1 % ≤ C < 1 %: Xn; R20/21/22 603-037-00-6 cellulose nitrate; nitrocellulose T——E; R3 E R: 3 S: (2-)35 603-046-00-5 bis(chloromethyl) ether; oxybis(chloromethane) E208-832-8542-88-1 F; R11 Carc. Cat. 1; R45 T+; R26 T; R24 Xn; R22 F; T+ R: 45-11-22-24-26 S: 53-45 C ≥ 25 %: T+; R45-22-24-26 7 % ≤ C < 25 %: T+; R45-21-26 3 % ≤ C < 7 %: T; R45-21-23 1 % ≤ C < 3 %: T; R45-23 0,1 % ≤ C < 1 %: T; R45-20 0,001 % ≤ C < 0,1 %: T; R45 603-064-00-3 1-methoxy-2-propanol; monopropylene glycol methyl ether 203-539-1107-98-2 R10 R67 R: 10-67 S: (2-) 603-066-00-4 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide 203-437-7106-87-6 Carc. Cat. 3; R40 T; R23/24/25 T R: 23/24/25-40

S: (1/2-)36/37-45-63 C ≥ 1 %: T; R23/24/25-40 0,1 % ≤ C < 1 %: Xn; R20/21/22 605-004-00-1 2,4,6-trimethyl-1,3,5-trioxane; paraldehyde 204-639-8123-63-7R10 R: 10 S: (2-)29 605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde 203-600-2108-62-3 F; R11 Xn; R22 F; Xn R: 11-22 S: (2-)13-16-25-46 606-021-00-7 N-methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone 212-828-1872-50-4 Repr. Cat. 2; R61 Xi; R36/37/38 T R: 61-36/37/38 S: 53-45 C ≥ 10 %: T; R61-36/37/38 5 % ≤ C < 10 %: T; R61 607-007-00-3salts of oxalic acid with the exception of those specified elsewhere in this AnnexA——Xn; R21/22 Xn R: 21/22 S: (2-)24/25 C ≥ 5 %: Xn; R21/22607-012-00-0benzoyl chloride202-710-898-88-4 Xn; R20/21/22 C; R34 R43 C R: 20/21/22-34-43 S: (1/2-)26-36/37/39-45 607-037-00-7 2-ethoxyethyl acetate; ethylglycol acetate E203-839-2111-15-9 R10 Repr. Cat. 2; R60-61 Xn; R20/21/22 T R: 60-61-10-20/21/22 S: 53-45 607-051-00-3 MCPA (ISO); 4-chloro-o-tolyloxyacetic acid 202-360-694-74-6 Xn; R22 Xi; R38-41 N; R50-53 Xn; N R: 22-38-41-50/53 S: (2-)26-37-39-60-61 607-052-00-9salts and esters of MCPAA—— Xn; R20/21/22 N; R50-53 Xn; N R: 20/21/22-50/53 S: (2-)13-60-61 607-085-00-9benzyl benzoate204-402-9120-51-4 Xn; R22 N; R51-53 Xn; N R: 22-51/53 S: (2-)25-46-61 607-095-00-3maleic acid203-742-5110-16-7 Xn; R22 Xi; R36/37/38 R43 Xn R: 22-36/37/38-43 S: (2-)24-26-28-37-46 C ≥ 25 %: Xn; R22-36/37/38-43 20 % ≤ C <25 %: Xi; R36/37/38-43 0,1 % ≤ C < 20 %: Xi; R43 607-103-00-5succinic anhydride203-570-0108-30-5 Xn; R22 Xi; R36/37 Xn R: 22-36/37 S: (2-)25-46 C ≥ 5 %: Xn; R22-36/37 1 % ≤ C < 5 %: Xi; R36/37 607-142-00-8 propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate 203-687-7109-61-5 F; R11 T; R23 C; R34 F; T R: 11-23-34 S: (1/2-)16-26-36-45 607-195-00-72-methoxy-1-methylethyl acetate203-603-9108-65-6R10 R: 10 S: (2-) 607-216-00-Xglutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine403-950-8— T+; R26 Xn; R22 C; R34 N; R50 T+; N R: 22-26-34-50 S: (1/2-)26-36/37/39-38-45-61 607-231-00-1 clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid 216-935-41702-17-6Xi; R41 Xi R: 41 S: (2-)26-39 607-245-00-8tert-butyl acrylateD216-768-71663-39-4 F; R11 Xn; R20/21/22 Xi; R37/38 R43 N; R51-53 F; Xn; N R: 11-20/21/22-37/38-43-51/53 S: (2-)16-25-37-61 C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53 20 % ≤ C < 25 %: Xi; R37/38-43-52/53 2,5 % ≤ C < 20 %: Xi; R43-52/53 1 % ≤ C < 2,5 %: Xi; R43 607-397-00-5 A mixture of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated) 415-930-6— Repr. Cat. 3; R62 R43 Xn R: 43-62 S: (2-)23-36/37 608-005-00-5n-butyronitrile203-700-6109-74-0 F; R11 T; R23/24/25 F; T R: 11-23/24/25 S: (1/2-)16-36/37-45-63 608-011-00-8 oxalonitrile; cyanogen 207-306-5460-19-5 F+; R12 T; R23 N; R50-53 F+; T; N R: 12-23-50/53 S: (1/2-)9-16-23-33-45-63-60-61 608-044-00-82-cyclohexylidene-2-phenylacetonitrile423-740-110461-98-0 Xn; R22

N; R51-53 Xn; N R; 22-51/53 S: (2-)46-61 609-007-00-9 2,4-dinitrotoluene; [1] dinitrotoluene [2] E 204-450-0 [1] 246-836-1 [2] 121-14-2 [1] 25321-14-6 [2] Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R23/24/25 Xn; R48/22 N; R50-53 T; N R: 45-23/24/25-48/22-62-68-50/53 S: 53-45-60-61 611-028-00-3C,C′-azodi(formamide)204-650-8123-77-3 E; R2 R42 E; Xn R: 2-42 S: (2-)22-24-37 611-035-00-1tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate403-660-1107246-80-0N; R51-53 N R: 51/53 S: 61 612-044-00-3N,N′-diacetylbenzidineE210-338-2613-35-4 Carc. Cat. 2; R45 Muta. Cat. 3; R68 Xn; R20/21/22 T R: 45-20/21/22-68 S: 53-45 612-050-00-6cyclohexylamine203-629-0108-91-8 R10 Repr. Cat. 3; R62 Xn; R21/22 C; R34 C R: 10-21/22-34-62 S: (1/2-)26-36/37/39-45 C ≥ 25 %: C; R21/22-34-62 10 % ≤ C < 25 %: C; R34-62 5 % ≤ C < 10 %: Xn; R36/38-62 2 % ≤ C < 5 %: Xi; R36/38 612-076-00-8ethyldimethylamine209-940-8598-56-1 F; R11 Xn; R20/22 C; R34 F; C R: 11-20/22-34 S: (1/2-)3-16-26-36-45 612-099-00-3 4-methyl-m-phenylenediamine; 2,4-toluenediamine E202-453-195-80-7 Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R25 Xn; R21-48/22 R43 N; R51-53 T; N R: 45-21-25-43-48/22-62-68-51/53 S: 53-45-61 612-101-00-2 methenamine; hexamethylenetetramine 202-905-8100-97-0 F; R11 R43 F; Xi R: 11-43 S: (2-)24-37 612-151-00-5 methyl-phenylene diamine; diaminotoluene; [technical product - mixture of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] E—— Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R25 Xn; R21-48/22 Xi; R36 R43 N; R51-53 T; N R: 45-21-25-36-43-48/22-62-68-51/53 S: 53-45-61 612-237-00-2 hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1); [1] hydroxylamine phosphate; [2] hydroxylamine dihydrogenphosphate; [3] hydroxylamine 4-methylbenzenesulfonate [4] T 233-154-4 [1] 244-077-0 [2] 242-818-2 [3] 258-872-5 [4] 10046-00-1 [1] 20845-01-6 [2] 19098-16-9 [3] 53933-48-5 [4] E; R2 Carc. Cat. 3; R40 Xn; R21/22-48/22 Xi; R36/38 R43 N; R50 E; Xn; N R: 21/22-36/38-40-43-48/22-50 S: (2-)36/37-61 613-116-00-7 tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 211-986-9731-27-1 T+; R26 T; R48/23 Xi; R36/37/38 R43 N; R50 T+; N R: 26-36/37/38-43-48/23-50 S: (1/2-)28-36/37/39-45-63-61 C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50 10 % ≤ C < 20 %: T+, N; R26-43-48/23-50 7 % ≤ C < 10 %: T+, N; R26-43-48/20-50 2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50 1 % ≤ C < 2,5 %: T; R23-43-48/20 0,1 % ≤ C < 1 %: Xn; R20 615-001-00-7methyl isocyanate210-866-3624-83-9 F; R11 Repr. Cat. 3; R63 T+; R26 T; R24/25 R42/43 Xi; R37/38-41 F; T+ R: 11-24/25-26-37/38-41-42/43-63 S: (1/2-)16-26-27/28-36/37/39-45-63 615-004-00-3salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexA—— Xn; R20/21/22 R32 R52-53 Xn R: 20/21/22-32-52/53

S: (2-)13-36/37-46-61 615-028-00-4ethyl 2-(isocyanatosulfonyl)benzoate410-220-277375-79-2 R14 Xn; R22-48/22 Xi; R41 R42/43 Xn R: 14-22-41-42/43-48/22 S: (2-)8-23-26-30-35-36/37/39 615-030-00-5alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexA—— Xn; R20/21/22 R32 R52-53 Xn R: 20/21/22-32-52/53 S: (2-)13-36/37-46-61 615-031-00-0thallium thiocyanate222-571-73535-84-0 T+; R26/28 Xn; R21 R32 R33 N; R51-53 T+; N R: 21-26/28-32-33-51/53 S: (1/2-)13-28-36/37-45-61 615-032-00-6metal salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexA—— Xn; R20/21/22 R32 N; R50-53 Xn; N R: 20/21/22-32-50/53 S: (2-)13-36/37-46-60-61 616-124-00-9lithium bis(trifluoromethylsulfonyl)imide415-300-090076-65-6 T; R24/25 Xn; R48/22 C; R34 R52-53 T R: 24/25-34-48/22-52/53 S: (1/2-)22-26-36/37/39-45-61 617-017-00-X A mixture of: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzene; 2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzene T412-140-332144-25-5 E; R2 O; R7 R53 E R: 2-7-53 S: (2-)3/7-14-36/37/39-61 650-016-00-2 Mineral wool, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] AQR——Carc. Cat. 3; R40 Xn R: 40 S: (2-)36/37 650-017-00-8 Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] AR——Carc. Cat. 2; R49 T R: 49 S: 53-45

Annex

ANNEX 1B Index NoChemical nameNotes related to substancesEC NoCAS NoClassificationLabellingConcentration LimitsNotes related to preparations003-003-00-5 (2-methylpropyl)lithium; isobutyllithium 440-620-2920-36-5 F; R15-17 R14 C; R35 R67 N; R50-53 F; C; N R: 14/15-17-35-67-50/53 S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61 005-013-00-5diethylmethoxyborane425-380-97397-46-8 F; R17 Xn; R20/21/22-48/22 C; R34 R43 R53 F; C R: 17-20/21/22-34-43-48/22-53 S: (1/2-)6-26-36/37/39-43-45-61 005-014-00-04-formylphenylboronic acid438-670-587199-17-5R43 Xi R: 43 S: (2-)24-37 005-017-00-7 sodium perborate; [1] perboric acid, sodium salt; [2] perboric acid, sodium salt, monohydrate; [3] sodium peroxometaborate; [4] perboric acid (HBO(O2)), sodium salt, monohydrate; [5] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] E 239-172-9 [1] 234-390-0 [2]

• [3] 231-556-4 [4]
• [5] 15120-21-5 [1] 11138-47-9 [2] 12040-72-1 [3] 7632-04-4 [4] 10332-33-9 [5] O; R8 Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xn; R22 Xi; R37-41 O; T R: 61-8-22-37-41-62 S: 53-45 C ≥ 25 %: T; R61-22-37-41-62 22 % ≤ C < 25 %: T; R61-37-41-62 20 % ≤ C < 22 %: T; R61-36/37-62 14 % ≤ C < 20 %: T; R61-36-62 9 % ≤ C < 14 %: T; R61-62 6,5 % ≤ C < 9 %: T; R61 005-017-01-4

sodium perborate; [1] perboric acid, sodium salt; [2] perboric acid, sodium salt, monohydrate; [3] sodium peroxometaborate; [4] perboric acid (HBO(O2)), sodium salt, monohydrate; [5] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] E 239-172-9 [1] 234-390-0 [2]

• [3] 231-556-4 [4]
• [5] 15120-21-5 [1] 11138-47-9 [2] 12040-72-1 [3] 7632-04-4 [4] 10332-33-9 [5] O; R8 Repr. Cat. 2; R61 Repr. Cat. 3; R62 T; R23 Xn; R22 Xi; R37-41 O; T R: 61-8-22-23-37-41-62 S: 53-45 C ≥ 25 %: T; R61-22-23-37-41-62 22 % ≤ C < 25 %: T; R61-20-37-41-62 20 % ≤ C < 22 %: T; R61-20-36/37-62 14 % ≤ C < 20 %: T; R61-20-36-62 9 % ≤ C < 14 %: T; R61-20-62 6,5 % ≤ C < 9 %: T; R61-20 3 % ≤ C < 6,5 %: Xn; R20 005-018-00-2 perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
• [1]
• [2]
• [3] 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xi; R37-41 T R: 61-37-41-62 S: 53-45-47 C ≥ 36 %: T; R61-37-41-62 22 % ≤ C < 36 %: T; R61-36/37-62 20 % ≤ C < 22 %: T; R61-37-62 14 % ≤ C < 20 %: T; R61-62 10 % ≤ C < 14 %: T; R61 005-018-01-X perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] E
• [1]
• [2]
• [3] 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xn; R20 Xi; R37-41 T R: 61-20-37-41-62 S: 53-45-47 C ≥ 36 %: T; R61-20-37-41-62 25 % ≤ C < 36 %: T; R61-20-36/37-62 22 % ≤ C < 25 %: T; R61-36/37-62 20 % ≤ C < 22 %: T; R61-37-62 14 % ≤ C < 20 %: T; R61-62 10 % ≤ C < 14 %: T; R61 006-097-00-61-phenyl-3-(p-toluenesulfonyl)urea424-620-113909-63-2 Xn; R22-48/22 R52-53 Xn R: 22-48/22-52/53 S: (2-)22-36-61 006-098-00-1tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate429-170-8134575-17-0 Xn; R22-48/22 Xi; R41 R43 Xn R: 22-41-43-48/22 S: (2-)22-26-36/37/39 006-099-00-7 N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea; 3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate 432-520-2232938-43-1N; R51-53 N R: 51/53 S: 22-61 006-101-00-6 mixture of: N,N″-(methylenedi-4,1-phenylene)bis[N′-phenylurea]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea; N,N″-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea] 423-070-8—R53 R: 53 S: 61 006-102-00-1O-hexyl-N-ethoxycarbonylthiocarbamateE432-750-3— Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R22-48/22 R43 N; R51-53 T; N R: 45-46-22-43-48/22-51/53 S: 53-45-61 006-103-00-7N,N″-(methylenedi-4,1-phenylene)bis[N′-octyl]urea445-760-8— Xi; R41 R42 N; R50-53 Xn; N R: 41-42-50/53 S: (2-)22-26-39-45-60-61 C ≥10 %: Xn, N; R41-42-50/53 5 % ≤ C < 10 %: Xn, N; R36-42-50/53

1 % ≤ C < 5 %: Xn, N; R42-50/53 0,25 % ≤ C < 1 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 ≤ C < 0,025 %: R52/53 007-029-00-8diethyldimethylammonium hydroxide419-400-595500-19-9 Xn; R21/22 C; R35 C R: 21/22-35 S: (1/2-)26-36/37/39-45 012-004-00-Xaluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate422-150-1—N; R50-53 N R: 50/53 S: 60-61 014-036-00-X(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane405-020-7105024-66-6 Repr.Cat.2; R60 N; R50-53 T; N R: 60-50/53 S: 53-45-60-61 C ≥ 0,5 %: T, N; R60-50/53 0,025 % ≤ C < 0,5 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 014-037-00-52-butanone-O,O′,O′′-(phenylsilylidyne)trioxime433-360-634036-80-1 Xn; R48/22 R43 R52-53 Xn R: 43-48/22-52/53 S: (2-)36/37-61 014-038-00-0S-(3-(triethoxysilyl)propyl)octanethioate436-690-9220727-26-4R43 Xi R: 43 S: (2-)24-37 014-039-00-6(2,3-dimethylbut-2-yl)-trimethoxysilane439-360-2142877-45-0 Xi; R38-41 R52-53 Xi R: 38-41-52/53 S: (2-)26-37/39-61 014-041-00-7N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane445-890-5201290-01-9 Xn; R22 R43 Xn R: 22-43 S: (2-)24-37 014-042-00-2mixture of: O,O′,O″,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)423-010-0—Xi; R41 Xi R: 41 S: (2-)26-39 014-043-00-8reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)432-200-2— F; R11 Xi; R37/38-41 R52-53 F; Xi R: 11-37/38-41-52/53 S: (2-)6-26-36/39-61 014-044-00-33-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane433-050-0—N; R51-53 N R: 51/53 S: 61 014-045-00-9magnesium sodium fluoride silicate442-650-1—Xn; R48/20 Xn R: 48/20 S: (2-)22-36 015-190-00-0 bis(2,4-dicumylphenyl) neopentyl diphosphite; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 421-920-2154862-43-8R53 R: 53 S: 61 015-191-00-6dodecyldiphenyl phosphate431-760-527460-02-2 Xi; R38 R52-53 Xi R: 38-52/53 S: (2-)37-61 015-192-00-1tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate432-770-2139189-30-3 R43 R53 Xi R: 43-53 S: (2-)24-37-61 015-193-00-7triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)442-960-7332350-93-3 T; R25 Xi; R41 N; R50-53 T; N R: 25-41-50/53 S: (1/2-)26-39-45-60-61 015-194-00-2tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate444-440-5220689-12-3 Xn; R22 R52-53 Xn R: 22-52/53 S: (2-)61 015-195-00-8 mixture of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate 433-860-4— Xi; R36 R43 R52-53 Xi R: 36-43-52/53 S: (2-)24-26-37-61 015-196-00-3 mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate 435-960-3— Carc.Cat.2; R45 Muta.Cat.2; R46 R43 T R: 45-46-43 S: 53-45 015-197-00-9bis(2,4,4-trimethylpentyl)dithiophosphonic acid420-160-9107667-02-7 R10 T; R23

Xn; R22 C; R34 N; R51-53 T; N R: 10-22-23-34-51/53 S: (1/2-)9-26-36/37/39-45-61 015-198-00-4(4-phenylbutyl)phosphinic acid420-450-586552-32-1 Carc.Cat.3; R40 Xi; R41 Xn R: 40-41 S: (2-)23-26-36/37/39 016-094-00-1sulfur231-722-67704-34-9Xi; R38 Xi R: 38 S: (2-)46 016-097-00-81-amino-2-methyl-2-propanethiol hydrochloride434-480-132047-53-3 Xn; R22 C; R34 R43 R52-53 C R: 22-34-43-52/53 S: (1/2-)22-26-36/37/39-45-61 017-009-01-8 ammonium perchlorate; [containing < 80 % of 0-30 μm particles] T232-235-17790-98-9 E; R2 O; R9 E R: 2-9 S: (2-)14-16-36/37 022-004-00-1potassium titanium oxide (K2Ti6O13)432-240-012056-51-8Carc.Cat.3; R40 Xn R: 40 S: (2-)22-36/37 022-005-00-7[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium419-840-8169104-71-6 F; R11 C; R34 R43 R53 F; C R: 11-34-43-53 S: (1/2-)6-9-16-26-36/37/39-45-61 028-002-01-4 nickel powder; [particle diameter < 1 mm] 231-111-47440-02-0 Carc. Cat. 3; R40 T; R48/23 R43 R52-53 T R: 40-43-48/23-52/53 S: (2-)36/37/39-45-61 028-013-00-7nickel matteE, H273-749-669012-50-6 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-014-00-2slimes and sludges, copper electrolytic refining, decopperised, nickel sulfateE295-859-392129-57-2 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 Xi; R38 R42/43 N; R50-53 T; N R: 49-61-20/22-38-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53 20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53 2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-015-00-8slimes and sludges, copper electrolyte refining, decopperisedE, H305-433-194551-87-8 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 1; R61 Repr. Cat. 3; R62 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-62-68-50/53 S: 53-45-60-61 028-016-00-3 nickel diperchlorate; perchloric acid, nickel(II) salt E, H237-124-113637-71-3 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 C; R34 R42/43 N; R50-53 T; N R: 49-61-34-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53 5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53 2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-017-00-9 nickel dipotassium bis(sulfate); [1] diammonium nickel bis(sulfate) [2] E, H 237-563-9 [1] 239-793-2 [2] 13842-46-1 [1] 15699-18-0 [2] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 R42/43 N; R50-53 T; N R: 49-61-20/22-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-018-00-4 nickel bis(sulfamidate); nickel sulfamate E, H237-396-113770-89-3 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-019-00-Xnickel bis(tetrafluoroborate)E, H238-753-414708-14-6 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-021-00-0 nickel diformate; [1] formic acid, nickel salt; [2] formic acid, copper nickel salt [3] E, H 222-101-0 [1] 239-946-6 [2] 268-755-0 [3] 3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C 0,1 %: Xi; R43 028-022-00-6 nickel di(acetate); [1] nickel acetate [2] E, H 206-761-7 [1] 239-086-1 [2] 373-02-4 [1] 14998-37-9 [2] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 R42/43 N; R50-53 T; N R: 49-61-20/22-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-024-00-7nickel dibenzoateE, H209-046-8553-71-9 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-025-00-2nickel bis(4-cyclohexylbutyrate)E, H223-463-23906-55-6 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61

T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-026-00-8 nickel(II) stearate; nickel(II) octadecanoate E, H218-744-12223-95-2 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-027-00-3nickel dilactateE, H—16039-61-5 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-028-00-9nickel(II) octanoateE, H225-656-74995-91-9 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat 2; R61 T; R48/23 C; R35 R42/43 N; R50-53 T; C; N R: 49-61-35-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53 10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53 5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53 2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-029-00-4 nickel difluoride; [1] nickel dibromide; [2] nickel diiodide; [3] nickel potassium fluoride [4] E, H 233-071-3 [1] 236-665-0 [2] 236-666-6 [3]

• [4] 10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-030-00-Xnickel hexafluorosilicateE, H247-430-726043-11-8 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-031-00-5nickel selenateE, H239-125-215060-62-5 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-032-00-0 nickel hydrogen phosphate; [1] nickel bis(dihydrogen phosphate); [2] trinickel bis(orthophosphate); [3] dinickel diphosphate; [4] nickel bis(phosphinate); [5] nickel phosphinate; [6] phosphoric acid, calcium nickel salt; [7] diphosphoric acid, nickel(II) salt [8] E, H 238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6]

• [7]
• [8] 14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 028-033-00-6diammonium nickel hexacyanoferrateE, H—74195-78-1 Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 028-034-00-1nickel dicyanideE, H209-160-8557-19-7 Carc. Cat. 1; R49 T; R48/23 R42/43 R32 N; R50-53 T; N R: 49-32-42/43-48/23-50/53 S: 53-45-60-61 028-035-00-7nickel chromateE, H238-766-514721-18-7 Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 028-036-00-2 nickel(II) silicate; [1] dinickel orthosilicate; [2] nickel silicate (3:4); [3] silicic acid, nickel salt; [4] trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] E, H 244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] 21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-037-00-8dinickel hexacyanoferrateE, H238-946-314874-78-3 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-038-00-3 trinickel bis(arsenate); nickel(II) arsenate E, H236-771-713477-70-8 Carc. Cat. 1; R45 T; R48/23 R43 N; R50-53 T; N R: 45-43-48/23-50/53 S: 53-45-60-61 028-039-00-9 nickel oxalate; [1] oxalic acid, nickel salt [2] E, H 208-933-7 [1] 243-867-2 [2] 547-67-1 [1] 20543-06-0 [2] Carc. Cat. 1; R49 T; R48/23 R43 N: R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-040-00-4nickel tellurideE, H235-260-612142-88-0 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-041-00-Xtrinickel tetrasulfideE, H—12137-12-1 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-042-00-5trinickel bis(arsenite)E, H—74646-29-0 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-043-00-0 cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332; [1] cobalt nickel dioxide; [2]

cobalt nickel oxide [3] E, H 269-051-6 [1] 261-346-8 [2]

• [3] 68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] Carc. Cat. 1; R49 T; R48/23 R43 T R: 49-43-48/23 S: 53-45 028-044-00-6 nickel tin trioxide; nickel stannate E, H234-824-912035-38-0 Carc. Cat. 1; R49 T; R48/23 R43 T R: 49-43-48/23 S: 53-45 028-045-00-1nickel triuranium decaoxideE, H239-876-615780-33-3 Carc. Cat. 1; R49 T; R48/23 R43 T R: 49-43-48/23 S: 53-45 028-046-00-7nickel dithiocyanateE, H237-205-113689-92-4 Carc. Cat. 1; R49 Muta. Cat. 3;R68 Repr. Cat. 2; R61 T; R48/23 R42/43 R32 N; R50-53 T; N R: 49-61-32-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-047-00-2nickel dichromateE, H239-646-515586-38-6 Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1% ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C 0,1 %: Xi; R43 028-048-00-8nickel(II) seleniteE, H233-263-710101-96-9 Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 028-049-00-3nickel selenideE, H215-216-21314-05-2 Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-050-00-9silicic acid, lead nickel saltE, H—68130-19-8 Carc. Cat. 1: R49 Repr. Cat. 1: R61 Repr. Cat. 3; R62 T; R48/23 R43 N; R50-53 T; N R: 49-61-43-48/23-62-50/53 S: 53-45-60-61 028-051-00-4 nickel diarsenide; [1] nickel arsenide [2] E, H 235-103-1 [1] 248-169-1 [2] 12068-61-0 [1] 27016-75-7 [2] Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-052-00-X nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900 E, H271-853-668610-24-2 Carc. Cat. 1: R49 T; R48/23 R43 T R: 49-43-48/23 S: 53-45 028-053-00-5 nickel dichlorate; [1] nickel dibromate; [2] ethyl hydrogen sulfate, nickel(II) salt [3] E, H 267-897-0 [1] 238-596-1 [2] 275-897-7 [3] 67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T: R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-054-00-0 nickel(II) trifluoroacetate; [1] nickel(II) propionate; [2] nickel bis(benzenesulfonate); [3] nickel(II) hydrogen citrate; [4] citric acid, ammonium nickel salt; [5]

citric acid, nickel salt; [6] nickel bis(2-ethylhexanoate); [7] 2-ethylhexanoic acid, nickel salt; [8] dimethylhexanoic acid nickel salt; [9] nickel(II) isooctanoate; [10] nickel isooctanoate; [11] nickel bis(isononanoate); [12] nickel(II) neononanoate; [13] nickel(II) isodecanoate; [14] nickel(II) neodecanoate; [15] neodecanoic acid, nickel salt; [16] nickel(II) neoundecanoate; [17] bis(D-gluconato-O1,O2)nickel; [18] nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19] nickel(II) palmitate; [20] (2-ethylhexanoato-O)(isononanoato-O)nickel; [21] (isononanoato-O)(isooctanoato-O)nickel; [22] (isooctanoato-O)(neodecanoato-O)nickel; [23] (2-ethylhexanoato-O)(isodecanoato-O)nickel; [24] (2-ethylhexanoato-O)(neodecanoato-O)nickel; [25] (isodecanoato-O)(isooctanoato-O)nickel; [26] (isodecanoato-O)(isononanoato-O)nickel; [27] (isononanoato-O)(neodecanoato-O)nickel; [28] fatty acids, C6-19-branched, nickel salts; [29] fatty acids, C8-18 and C18-unsaturated, nickel salts; [30] 2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] E, H 240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] 294-302-1 [29] 283-972-0 [30]

• [31] 16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 028-055-00-6 nickel(II) sulfite; [1] nickel tellurium trioxide; [2] nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4] E, H 231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] 7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 028-056-00-1 nickel boride (NiB); [1] dinickel boride; [2] trinickel boride; [3] nickel boride; [4] dinickel silicide; [5] nickel disilicide; [6] dinickel phosphide; [7] nickel boron phosphide [8] E, H 234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4]

235-033-1 [5] 235-379-3 [6] 234-828-0 [7]

• [8] 12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 T; N R: 49-43-48/23-50/53 S: 53-45-60-61 028-057-00-7 dialuminium nickel tetraoxide; [1] nickel titanium trioxide; [2] nickel titanium oxide; [3] nickel divanadium hexaoxide; [4] cobalt dimolybdenum nickel octaoxide; [5] nickel zirkonium trioxide; [6] molybdenum nickel tetraoxide; [7] nickel tungsten tetraoxide; [8] olivine, nickel green; [9] lithium nickel dioxide; [10] molybdenum nickel oxide; [11] E, H 234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9]
• [10]
• [11] 12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] Carc. Cat. 1; R49 T; R48/23 R43 T R: 49-43-48/23 S: 53-45 028-058-00-2cobalt lithium nickel oxideE442-750-5— Carc. Cat. 1; R49 T+; R26 T; R48/23 R43 N; R50-53 T+; N R: 49-26-43-48/23-50/53 S: 53-45-60-61 029-014-00-5 mixture of: 2,2′-[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]N,N′,O,O′-copper complex; 2,2′-[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]N,N′,O,O′-copper complex 419-610-7171866-24-3 Xn; R48/22 N; R51-53 Xn; N R: 48/22-51/53 S: (2-)22-36-61 030-012-00-1aluminium-magnesium-zinc-carbonate-hydroxide423-570-6169314-88-9R52-53 R: 52/53 S: 61 030-015-00-8tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate440-060-9—N; R51-53 N R: 51/53 S: 61 042-005-00-0 mixture of: mono- and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl]; N,N-diorgano dithiocarbamate molybdenum complex 434-240-6— R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)24-37-61 050-023-00-5 mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane 422-920-5— Xn; R48/22 N; R50-53 Xn; N R: 48/22-50/53 S: (2-)23-36-60-61 C ≥ 10 %: Xn, N; R48/22-50/53 2,5 % ≤ C < 10 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 050-024-00-0 mixture of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane 432-230-6— T; R48/25 Xn; R22 Xi; R38-41 R43 N; R50-53 T; N R: 22-38-41-43-48/25-50/53 S: (1/2-)22-26-36/37/39-45-60-61 064-001-00-8gadolinium(III)sulfite trihydrate456-900-251285-81-5N; R51-53 N R: 51/53 S: 61 078-011-00-5hydroxydisulfito platinum(II) acid423-310-161420-92-6 Xn; R22-48/20/21/22 C; R35 R42/43 R52-53 C R: 22-35-42/43-48/20/21/22-52/53 S: (1/2-)23-24-26-28-36/37/39-45-61 078-012-00-0platinum(IV) nitrate/nitric acid solution432-400-1— C; R35 N; R50-53 C; N R: 35-50/53 S: (1/2-)26-36/37/39-45-60-61 082-012-00-6barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped431-780-4199876-46-5

Xn; R22-48/22 N; R51-53 Xn; N R: 22-48/22-51/53 S: (2-)22-36-61 601-080-00-5 mixture of: sec-butylphenyl(phenyl)methane, mixed isomers; 1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers; 1-(sec-butylphenyl-1-phenylethane, mixed isomers 431-100-6—N; R50-53 N R: 50/53 S: 60-61 601-081-00-0cyclohexadeca-1,9-diene431-730-14277-06-9 Xi; R38 R43 R53 Xi R: 38-43-53 S: (2-)36/37-61 601-082-00-6 mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane 434-420-4— Xi; R38-41 N; R50-53 Xi; N R: 38-41-50/53 S: (2-)23-26-37/39-57-60-61 601-083-00-15-endo-hexyl-bicyclo[2.2.1]hept-2-ene435-000-322094-83-3 Xn; R65 Xi; R38 R53 Xn R: 38-65-53 S: (2-)37-62-61 601-084-00-7 mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) 435-180-3— Xn; R65 Xi; R38 N; R50-53 Xn; N R: 38-65-50/53 S: (2-)37-62-60-61 602-105-00-2sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate422-100-7102061-82-5 Xi; R41 R43 Xi R: 41-43 S: (2-)24-26-37/39 602-106-00-82-bromo-4,6-difluoroaniline429-430-0444-14-4 Xn; R22 N; R51-53 Xn; N R: 22-51/53 S: (2-)25-61 602-107-00-33,3,4,4-tetrafluoro-4-iodo-1-butene439-500-233831-83-3 Xn; R22 Xi; R38 N; R51-53 Xn; N R: 22-38-51/53 S: (2-)37-61 602-108-00-9(2,3,5,6-tetrafluorophenyl)methanol443-840-74084-38-2 Xn; R22 Xi; R36 R43 Xn R: 22-36-43 S: (2-)26-36/37 603-211-00-1 2,3-epoxypropyltrimethylammonium chloride … %; glycidyl trimethylammonium chloride … % B E221-221-03033-77-0 Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 Xn; R21/22-48/22 Xi; R41 R43 R52-53 T R: 45-21/22-41-43-48/22-62-68-52/53 S: 53-45-61 603-212-00-7 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide; (HHCB) 214-946-91222-05-5N; R50-53 N R: 50/53 S: 60-61 603-213-00-2 2-methoxy-2-methylbutane; tert-amyl methyl ether 213-611-4994-05-8 F; R11 Xn; R22 R67 F; Xn R: 11-22-67 S: (2-)9-16-23-33 603-214-00-81,1-diisopropoxycyclohexane413-740-81132-95-2C; R34 C R: 34 S: (1/2-)23-26-36/37/39-45 603-215-00-31-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)418-330-2162241-33-0 E; R2 Xn; R22-48/22 Xi; R41 R43 N; R50-53 E; Xn; N R: 2-22-41-43-48/22-50/53 S: (2-)22-26-36/37/39-60-61 603-216-00-9cis-1-amino-2,3-dihydro-1H-inden-2-ol422-660-27480-35-5 Xi; R41 R43 R52-53 Xi R: 41-43-52/53 S: (2-)24-26-37/39-61 603-217-00-42,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite423-560-1161717-32-4 R43 R53 Xi R: 43-53 S: (2-)24-37/39-61 603-220-00-01-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol432-890-572955-94-3R53 R: 53 S: 61 603-221-00-6 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)] 433-580-2214353-17-0 Xn; R22 C; R34 N; R51-53 C; N R: 22-34-51/53 S: (1/2-)26-36/37/39-45-61 603-221-01-3 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)] E433-580-2214353-17-0 Carc. Cat. 2; R45 Xn; R22 C; R34 N; R51-53 T; N R: 45-22-34-51/53 S: 53-45-61 603-222-00-1(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane433-820-6118058-74-5Xi; R36 Xi R: 36 S: (2-)26 603-223-00-7 2-cyclopentylidene cyclopentanol; 1,1′-bi(cyclopentyliden)-2-ol 434-270-16261-30-9 Xi; R38-41 R52-53 Xi R: 38-41-52/53 S: (2-)26-37/39-61 603-224-00-23-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane435-790-1297730-93-9R53 R: 53 S: 61 603-225-00-8 erythromycin A9-oxime (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) 437-070-013127-18-9N; R51-53 N R: 51/53 S: 61 603-226-00-34,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol444-500-01440-00-2R52-53 R: 52/53 S: 61 603-227-00-9 α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate 445-060-2203574-04-3 O; R7 N; R50-53 O; N R: 7-50/53 S: (2-)3/7-14-36/37/39-60-61 603-228-00-4 (+/-)-(R,R)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane 419-620-1— R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)36/37-61 603-229-00-Xsodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate420-800-7— Xi; R38-41 R43 N; R50-53 Xi; N R: 38-41-43-50/53 S: (2-)24-26-37/39-60-61 603-230-00-52,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan440-030-5— Xi; R38-41 R53 Xi R: 38-41-53 S: (2-)26-37/39-61 603-231-00-0(S)-1,1-diphenyl-1,2-propanediol443-220-6—R52-53 R: 52/53 S: 22-61 603-232-00-63,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane444-420-6—R53 R: 53 S: 61 603-233-00-1 mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol 444-430-0—N; R51-53 N R: 51/53 S: 61 603-234-00-7(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene444-480-3— Xi; R38 N; R51-53 Xi; N R: 38-51/53 S: (2-)37-61 604-074-00-0 tetrabromobisphenol-A; 2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol 201-236-979-94-7N; R50-53 N R: 50/53 S: 60-61

604-075-00-6 4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol 205-426-2140-66-9 Xi; R38-41 N; R50-53 Xi; N R: 38-41-50/53 S: (2-)26-37/39-60-61 C ≥ 20 %: Xi, N; R38-41-50/53 10 % ≤ C < 20 %: Xi, N; R41-50/53 5 % ≤ C < 10 %: Xi, N; R36-50/53 2,5 % ≤ C < 5 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 604-076-00-1phenolphthalein201-004-777-09-8 Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T R: 45-62-68 S: 53-45 C ≥ 5 %: T; R45-62-68 1 % ≤ C < 5 %: T; R45-68 604-077-00-72-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol419-750-998809-58-6R53 R: 53 S: 61 604-079-00-84,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol428-970-413595-25-0 Repr.Cat.3; R62 R43 N; R51-53 Xn; N R: 43-62-51/53 S: (2-)22-36/37-61 604-080-00-34-fluoro-3-trifluoromethylphenol432-560-061721-07-1 Xn; R20 C; R35 R43 N; R51-53 C; N R: 20-35-43-51/53 S: (1/2-)26-28-36/37/39-45-61 604-081-00-91,1-bis(4-hydroxyphenyl)-1-phenylethane433-130-51571-75-1N; R50-53 N R: 50/53 S: 25-60-61 604-082-00-42-chloro-6-fluoro-phenolE433-890-82040-90-6 Muta.Cat.2; R46 Repr.Cat.3; R62 Xn; R22 C; R34 R43 N; R51-53 T; N R: 46-22-34-43-62-51/53 S: 53-45-61 604-083-00-X4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol439-270-3260408-02-4R53 R: 53 S: 61 604-084-00-51-ethoxy-2,3-difluorobenzene441-000-4121219-07-6 Xn; R22 R52-53 Xn R: 22-52/53 S: (2-)23-61 604-087-00-1 mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol 433-640-8— F; R17 R44 R53 F R: 17-44-53 S: (2-)15-22-61 604-089-00-22-methyl-5-tert-butylthiophenol444-970-7— R10 Repr.Cat.3; R63 Xn; R48/20/22-65 Xi; R36/38 R43 R67 N; R50-53 Xn; N R: 10-36/38-43-48/20/22-63-65-67-50/53 S: (2-)26-36/37-62-60-61 605-037-00-1 trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde 421-800-1120578-03-2R53 R: 53 S: 22-61 605-038-00-73-methyl-5-phenylpentan-1-al433-900-055066-49-4 Xn; R22 Xi; R38 R43 N; R51-53 Xn; N R: 22-38-43-51/53 S: (2-)36/37-61 605-039-00-23,4-dihydroxy-5-nitrobenzaldehyde441-810-8116313-85-0 Xn; R22 Xi; R41 R43 Xn R: 22-41-43 S: (2-)22-24-26-37/39 606-124-00-71-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione421-080-7161462-35-7 Xn; R48/22 N; R50-53 Xn; N R: 48/22-50/53 S: (2-)36-60-61 606-125-00-21-benzylimidazolidine-2,4-dione421-340-16777-05-5Xn; R22 Xn R: 22 S: (2-)22 606-126-00-81,4-bis(2,3-dihydroxypropylamino)anthraquinone421-470-799788-75-7N; R51-53 N R: 51/53 S: 61 606-128-00-92,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione422-650-8148935-94-8R53 R: 53

S: 61 606-129-00-4 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one 423-090-7156732-13-7R53 R: 53 S: 61 606-130-00-X4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone423-860-256309-94-5 R43 R52-53 Xi R: 43-52/53 S: (2-)24-37-61 606-131-00-5cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dioneE427-230-85571-36-8 Repr. Cat. 2; R60 Xn; R48/22 N; R51-53 T; N R: 60-48/22-51/53 S: 53-45-61 606-132-00-0(6β)-6,19-epoxyandrost-4-ene-3,17-dione433-490-36563-83-3 R43 R52-53 Xi R: 43-52/53 S: (2-)24-37-61 606-134-00-1androsta-1,4,9(11)-triene-3,17-dione433-560-315375-21-0Repr. Cat.3; R62 Xn R: 62 S: (2-)22-36/37 606-135-00-7cyclohexadecanone438-930-82550-52-9R53 R: 53 S: 61 606-136-00-2(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone444-350-6133413-70-4 Xi; R36 R53 Xi R: 36-53 S: (2-)26-61 606-137-00-8trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione444-750-0211387-26-7R53 R: 53 S: 22-61 606-138-00-3(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone444-800-1141645-23-0 R10 Xn; R22-48/22 Xi; R38-41 R43 N; R50-53 Xn; N R: 10-22-38-41-43-48/22-50/53 S: (2-)23-26-36/37/39-60-61 C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53 20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53 10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 606-139-00-9(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one444-830-5124379-29-9R53 R: 53 S: 61 606-140-00-42-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one444-860-9474510-57-1 Xn; R48/22 N; R50-53 Xn; N R: 48/22-50/53 S: (2-)22-36-60-61 606-141-00-Xsodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate418-410-7—Xi; R36 Xi R: 36 S: (2-)26 606-142-00-5 mixture of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one 434-290-9— Xn; R22 N; R51-53 Xn; N R: 22-51/53 S: (2-)61 607-580-00-Xethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate422-360-1100491-29-0 R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)22-24-37-61 607-618-00-5 menadione sodium bisulfite; 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt 204-987-0130-37-0 Xi; R36/38 N; R50-53 Xi; N R: 36/38-50/53 S: (2-)24/25-60-61 607-619-00-0 menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) 277-543-773581-79-0 Xi; R36/38 N; R50-53 Xi; N R: 36/38-50/53 S: (2-)24/25-60-61 607-620-00-6trisodium nitrilotriacetate225-768-65064-31-3

Carc. Cat. 3; R40 Xn; R22 Xi; R36 Xn R: 22-36-40 S: (2-)26-36/37-46 C ≥ 25 %: Xn; R22-36-40 20 ≤ % C < 25 %: Xn; R36-40 5 ≤ % C < 20 %: Xn; R40 607-621-00-1 milbemectin (ISO); [mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] —— Xn; R20/22 N; R50-53 Xn; N R: 20/22-50/53 S: (2-)46-60-61 C ≥ 25 %: Xn, N; R20/22-50/53 0,25 % ≤ C < 25 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 607-622-00-72-ethylhexyl-2-ethylhexanoate231-057-17425-14-1Repr. Cat. 3; R63 Xn R: 63 S: (2-)36/37 607-623-00-2diisobutyl phthalate201-553-284-69-5 Repr. Cat. 2; R61 Repr. Cat. 3; R62 T R: 61-62 S: 53-45 C ≥ 25 %: T; R61-62 5 % ≤ C < 25 %: Xn; R62 607-624-00-8 perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] E 217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] 1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] Carc. Cat. 3; R40 Repr. Cat. 2; R61 T; R48/25 Xn; R20/22 R64 N; R51-53 T; N R: 61-20/22-40-48/25-64-51/53 S: 53-45-61 607-625-00-3clodinafop-propargyl (ISO)—105512-06-9 Xn; R22-48/22 R43 N; R50-53. Xn; N R: 22-43-48/22-50/53 S: (2-)24-36/37-46-60-61 C ≥ 25 %: Xn, N; R22-43-48/22-50/53 10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53 2,5 % ≤ C < 10 %: Xi, N; R43-51/53 0,25 % ≤ C < 2,5 %: Xi; R43-52/53 0,001 % ≤ C < 0,25 %: Xi; R43 607-626-00-9ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate401-290-5103112-35-2 Carc.Cat.2; R45 N; R50-53 T; N R: 45-50/53 S: 53-45-60-61 607-627-00-4[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate416-360-0162221-28-5R43 Xi R: 43 S: (2-)22-24-37 607-628-00-X4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine419-240-6171054-89-0Xi; R41 Xi R: 41 S: (2-)26-39 607-629-00-5[2-methyl-1-(1-oxopropoxy)propoxyphosphinyl] acetic acid419-270-1123599-82-6Xi; R36 Xi R: 36 S: (2-)26 607-630-00-0acrylic acid, 3-(trimethoxysilyl)propyl ester419-560-64369-14-6 Xn; R20 C; R34 R43 R52-53 C R: 20-34-43-52/53 S: (1/2-)26-36/37/39-45-61 607-631-00-6 mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate 442-300-8—R43 Xi R: 43 S: (2-)24-37 607-632-00-1N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide420-210-1111244-14-5R53 R: 53 S: 61 607-633-00-7trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate440-480-2341026-59-3 Xi; R41 R43 Xi R: 41-43 S: (2-)22-24-26-37/39 607-634-00-2 (S)-(-)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate 420-610-436394-75-9

Xn; R22 C; R34 R43 C R: 22-34-43 S: (1/2-)23-26-36/37/39-45 607-635-00-8trisodium N-(3-propionato)-L-aspartate422-090-4172737-80-3Xi; R41 Xi R: 41 S: (2-)26-39 607-636-00-31-bromo-2-methylpropyl propionate422-900-6158894-67-8 R10 Carc.Cat.3; R40 C; R34 R43 C R: 10-34-40-43 S: (1/2-)7/9-8-23-26-36/37/39-45 607-637-00-9disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate423-730-5250688-43-8Xi; R41 Xi R: 41 S: (2-)26-39 607-638-00-42-hydroxybenzoic acid 2-butyloctyl ester431-090-3190085-41-7R53 R: 53 S: 61 607-639-00-X2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate431-770-1216698-07-6R53 R: 53 S: 61 607-641-00-0 2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid 431-930-943028-69-9 Xn; R22 R43 Xn R: 22-43 S: (2-)22-24-37 607-642-00-63,6,9-trithiaundecamethylene-1,11-dimethacrylate432-210-7141631-22-3N; R50-53 N R: 50/53 S: 60-61 607-643-00-1dimethyl (2S)-2-hydroxysuccinate432-310-0617-55-0 R10 Xi; R41 R43 Xi R: 10-41-43 S: (2-)24-26-37/39-43 607-644-00-7methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate432-350-981752-87-6Xi; R38 Xi R: 38 S: (2-)37 607-645-00-2tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate432-550-6243858-01-7Xi; R41 Xi R: 41 S: (2-)22-26-39 607-646-00-8 D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate 432-960-5124655-09-0Xn; R22 Xn R: 22 S: (2-)25 607-647-00-35-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane433-530-1143446-73-5 Xn; R22 R43 N; R50 Xn; N R: 22-43-50 S: (2-)24-37-57-61 607-649-00-4[3-(chlorocarbonyl)-2-methylphenyl]acetate433-690-0167678-46-8 C; R35 R43 C R: 35-43 S: (1/2-)7/8-26-36/37/39-45 607-650-00-X2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate433-910-5145153-52-2R43 Xi R: 43 S: (2-)24-37 607-651-00-5sodium 2-(nonanoyloxy)benzenesulfonate434-360-991125-43-8 Xi; R41 R43 Xi R: 41-43 S: (2-)24-26-37/39 607-652-00-0ethyl N2-dodecanoyl-L-argininate hydrochloride434-630-660372-77-2 Xi; R41 N; R50 Xi; N R: 41-50 S: (2-)26-39-61 607-653-00-6tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate434-840-8225786-91-4N; R51-53 N R: 51/53 S: 61 607-654-00-1(S)-3-hydroxy-γ-butyrolactone434-990-47331-52-4R43 Xi R: 43 S: (2-)23-24-37 607-655-00-7ethyl 6,8-dichlorooctanoate435-080-11070-64-0 R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)24-37-61 607-656-00-2sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid435-350-7141250-43-3 Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)22-26-39-61 607-657-00-8pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate436-920-8172399-10-9Xi; R41

Xi R: 41 S: (2-)22-26-39 607-658-00-33,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt440-770-9371921-63-0 Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)26-39-61 607-659-00-9pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid442-030-0321912-47-4Xi; R41 Xi R: 41 S: (2-)22-26-39 607-660-00-42-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt442-230-8321679-52-1Xi; R41 Xi R: 41 S: (2-)22-26-39 607-661-00-X1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate442-850-9114772-40-6 R43 R53 Xi R: 43-53 S: (2-)22-24-37-61 607-662-00-5methyl 2-(acetylamino)-3-chloropropionate442-860-387333-22-0 R43 N; R50-53 Xi; N R: 43-50/53 S: (2-)24-37-60-61 607-663-00-0bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate442-980-6127474-91-3R53 R: 53 S: 61 607-664-00-6methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate443-120-2393509-79-0 Xi; R41 N; R51-53 Xi; N R: 41-51/53 S: (2-)26-39-61 607-665-00-1trans-methyl-2-ethyl-but-2-enoate443-150-6101226-85-1R10 R: 10 S: 23 607-666-00-7(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid443-560-588784-33-2Xi; R36 Xi R: 36 S: (2-)26 607-667-00-2chloro-1-ethylcyclohexyl carbonate444-950-899464-83-2 Muta.Cat.3; R68 R43 Xn R: 43-68 S: (2-)23-36/37 607-668-00-8trans-2-isopropyl-5-carboxy-1,3-dioxane445-770-242031-28-7 Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)22-26-39-61 607-669-00-3methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate445-990-9376588-17-9 R43 R53 Xi R: 43-53 S: (2-)24-37-61 607-670-00-9 dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate 448-700-9500791-70-8 Xn; R48/22 Xi; R41 R43 N; R50-53 Xn; N R: 41-43-48/22-50/53 S: (2-)22-26-36/37/39-60-61 C ≥ 10 %: Xn, N; R41-43-48/22-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 607-671-00-4diethyl 1,4-cyclohexanedicarboxylate417-310-072903-27-6N; R51-53 N R: 51/53 S: 61 607-672-00-X mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate 419-000-0— R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)24-37-61 607-673-00-51-ethyl-5,6,7,8-tetrahydroquinolinium tosylate419-570-0— Xn; R22 R52-53 Xn R: 22-52/53 S: (2-)61 607-674-00-0branched C10-alkyl benzoates421-090-1131298-44-7Xn; R20 Xn R: 20 S: (2-)23 607-675-00-6 mixture of: cis-9-octadecenedioic acid;

cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid 422-260-8— Xi; R41 N; R50-53 Xi; N R: 41-50/53 S: (2-)26-39-60-61 607-676-00-1 mixture of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid 423-670-1— Xi; R41 R43 Xi R: 41-43 S: (2-)24-26-37/39 607-677-00-72,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate424-660-8— Xn; R48/22 Xi; R41 R43 Xn R: 41-43-48/22 S: (2-)22-26-36/37/39 607-678-00-2 mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate 427-090-8— R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)23-25-36/37-61 607-679-00-8 mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate) 431-440-5— Xi; R41 N; R51-53 Xi; N R: 41-51/53 S: (2-)22-26-39-61 607-680-00-3tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate432-810-9—R53 R: 53 S: 61 607-681-00-9 mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate 432-910-2—R53 R: 53 S: 61 607-682-00-4complex mixture of Chinese gum rosin post reacted with acrylic acid434-230-1144413-22-9R53 R: 53 S: 61 607-683-00-X mixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) 435-450-0— R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)24-37-61 607-684-00-5alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts435-660-2243662-67-1 Xi; R38 R43 Xi R: 38-43 S: (2-)24-37 607-685-00-0ammonium 2-cocoyloxyethanesulfonate441-050-7—Xi; R38-41 Xi R: 38-41 S: (2-)26-37/39 607-686-00-66,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)441-550-5— E; R2 F; R11 Carc. Cat. 3; R40 E; Xn R: 2-11-40 S: (2-)7-22-36/37 607-687-00-1 mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %) 442-800-6— Xi; R38 N; R51-53 Xi; N R: 38-51/53 S: (2-)37-61 607-688-00-7(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride444-320-2—Xn; R22 Xn R: 22 S: (2-) 607-689-00-2 mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (para-isomer including cis- and trans- isomers); methyl 1,3-dimethylcyclohexanecarboxylate (meta-isomer including cis- and trans-isomers) 444-920-4—R52-53 R: 52/53 S: 61 607-690-00-8dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate432-860-1255387-46-3R43 Xi R: 43 S: (2-)24-37 607-691-00-3magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear448-690-6—R53 R: 53 S: 61 607-692-00-9zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear446-470-4—R53 R: 53 S: 61 607-693-00-4hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate443-860-6302776-68-7R53 R: 53 S: 61 607-694-00-Xethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate443-870-0163520-33-0 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)22-36/37-60-61 608-042-00-7(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide421-810-4194602-27-2 Xn; R22 Xi; R41 R43 N; R51-53 Xn; N R: 22-41-43-51/53 S: (2-)24-26-37/39-61 608-059-00-X5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile421-240-6120068-79-3N; R51-53 N R: 51/53 S: 22-61 608-060-00-55-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile421-300-1138564-59-7N; R50-53 N R: 50/53 S: 22-60-61 608-062-00-62-fluoro-4-hydroxybenzonitrile422-810-782380-18-5 Xn; R22 Xi; R41 N; R51-53 Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 608-063-00-1(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile441-070-661826-76-4 T; R25 Xi; R41 R43 N; R50-53 T; N R: 25-41-43-50/53 S: (1/2-)9-26-36/37/39-45-60-61 608-064-00-7cyanomethyltrimethylammoniummethylsulfate433-720-2—R52-53 R: 52/53 S: 61 609-069-00-7 musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone 201-328-981-14-1 Carc. Cat. 3; R40 N; R50-53 Xn; N R: 40-50/53 S: (2-)36/37-46-60-61 611-154-00-9trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate403-670-692408-46-3R52-53

R: 52/53 S: 61 611-155-00-44,4′-oxybis(benzenesulfonylazide)431-850-47456-68-0 E; R3 F; R11 Xn; R48/22 N; R50-53 E; Xn; N R: 3-11-48/22-50/53 S: (2-)14-22-33-35-36-60-61 611-156-00-Xtriammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate432-270-4221354-37-6 Repr. Cat. 3; R62 Xn; R48/22 N; R51-53 Xn; N R: 48/22-62-51/53 S: (2-)36/37-61 611-157-00-5 benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt; potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate 432-590-4243869-48-9 Xi; R36 R52-53 Xi R: 36-52/53 S: (2-)26-61 611-158-00-0reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride421-520-8— F; R11 R53 F R: 11-53 S: (2-)3-12-16-33-61 611-159-00-6disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate421-880-6— Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)26-39-61 611-160-00-1 mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane; 1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane; reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1); reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) 422-760-6— F; R11 R53 F R: 11-53 S: (2-)3-12-33-61 611-161-00-7trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)423-100-1—Xi; R41 Xi R: 41 S: (2-)26-39 611-162-00-22,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)429-600-4— Xn; R22 Xi; R41 N; R51-53 Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 611-163-00-82,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate429-610-9— Xn; R22 Xi; R41 N; R51-53 Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 611-164-00-3 mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile; 2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile); 2,2′-dimethyl-2,2′-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile) 429-710-2— R10 R32 R44 Xn; R22 N; R51-53 Xn; N R: 10-22-32-44-51/53 S: (2-)12-15-16-47-51-61 611-165-00-9 mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate

431-830-5—R52-53 R: 52/53 S: 61 611-166-00-4 mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate 432-100-9— Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)26-39-61 611-167-00-Xsodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II)435-240-9—R52-53 R: 52/53 S: 61 611-168-00-5 mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid 435-440-6—Xi; R41 Xi R: 41 S: (2-)22-26-39 611-169-00-0sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate435-800-2—R52-53 R: 52/53 S: 61 611-170-00-6 mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II); disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II) 435-880-9—R52-53 R: 52/53 S: 22-61 611-171-00-1 mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate 436-890-6— Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)22-26-39-61 611-172-00-7 mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate 438-310-7— E; R2 Repr. Cat. 3; R62 Xn; R22-48/22 R52-53 E; Xn R: 2-22-48/22-62-52/53 S: (2-)22-35-36/37-61 611-173-00-2 mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt 440-510-4— Xi; R41 R43 Xi R: 41-43 S: (2-)22-26-36/37/39 611-174-00-8 mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;

3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt 442-290-5457624-86-1Xi; R41 Xi R: 41 S: (2-)22-26-39 611-175-00-3 mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate 444-050-5— Xi; R41 R52-53 Xi R: 41-52/53 S: (2-)22-26-39-61 611-176-00-92,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate444-250-2— E; R2 F; R11 N; R51-53 E; N R: 2-11-51/53 S: (2-)22-61 611-177-00-4 mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III); tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III); trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III) 444-290-0508202-43-5 Xi; R41 R43 R52-53 Xi R: 41-43-52/53 S: (2-)22-24-26-37/39-61 611-178-00-X mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate 445-280-9— Xi; R41 R43 R52-53 Xi R: 41-43-52/53 S: (2-)24-26-37/39-61 611-179-00-5 mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate

450-010-8— Xi; R41 R43 Xi R: 41-43 S: (2-)22-24-26-37/39 611-180-00-0iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts417-850-7—N; R51-53 N R: 51/53 S: 22-61 612-238-00-8(3-chloro-2-hydroxypropyl) trimethylammonium chloride … %B222-048-33327-22-8 Carc. Cat. 3, R40 R52-53 Xn R: 40-52/53 S: 36/37-61 612-239-00-3 biphenyl-3,3′,4,4′-tetrayltetraamine; diaminobenzidine 202-110-691-95-2 Carc. Cat. 2; R45 Muta. Cat. 3; R68 T R: 45-68 S: 53-45 612-240-00-9 pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl)aniline —53112-28-0N; R51-53 N R: 51/53 S: 61 612-241-00-4 piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3] 228-042-7 [1] 205-551-2 [2] 217-775-8 [3] 6094-40-2 [1] 142-64-3 [2] 1951-97-9 [3] Repr. Cat. 3; R62-63 Xi; R36/38 R42/43 R52-53 Xn R: 36/38-42/43-62-63-52/53 S: (1/2-)22-36/37-45-63-61 612-242-00-X cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine —121552-61-2 R43 N; R50-53 Xi; N R: 43-50/53 S: (2-)24-37-46-60-61 C ≥ 2,5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 612-243-00-5(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate420-560-379617-97-3 Xi; R41 N; R50-53 Xi; N R: 41-50/53 S: (2-)26-39-60-61 C ≥ 10 %: Xi, N; R41-50/53 5 % ≤ C < 10 %: Xi, N; R36-50/53 2,5 % ≤ C < 5 %: N; R50/53 0,25 % ≤ C < 2, 5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 612-244-00-03-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride421-310-687691-88-1 Repr. Cat. 3; R62 Xn; R22 Xi; R36 R43 N; R50-53 Xn; N R: 22-36-43-62-50/53 S: (2-)22-26-36/37/39-60-61 612-245-00-62-ethylphenylhydrazine hydrochloride421-460-219398-06-2 Carc. Cat. 3; R40 T; R48/25 Xn; R22 Xi; R41 R43 N; R50-53 T; N R: 22-40-41-43-48/25-50/53 S: (1/2-)22-26-36/37/39-45-60-61 C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53 10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53 5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53 2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 612-246-00-1(2-chloroethyl)(3-hydroxypropyl)ammonium chlorideE429-740-640722-80-3 Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R48/22 R43 R52-53 T R: 45-46-43-48/22-52/53 S: 53-45-61 612-247-00-7N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide423-530-8152828-23-4 T; R48/25 Xn; R22 R52-53 T R: 22-48/25-52/53 S: (1/2-)22-36-45-61 612-248-00-2reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)439-540-0— Xi; R38 R43 R53 Xi R: 38-43-53 S: (2-)24-37-61 612-249-00-84-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride425-030-5159939-85-2 Repr. Cat. 3; R62 Xn; R22 C; R34 R43 N; R51-53

C; N R: 22-34-43-62-51/53 S: (1/2-)22-26-36/37/39-45-61 612-250-00-3chloro-N,N-dimethylformiminium chlorideE425-970-63724-43-4 R14 Repr. Cat. 2; R61 Xn; R22 C; R35 T; C R: 61-14-22-35 S: 53-45 612-251-00-9cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride426-020-351229-78-8 F; R11 Repr. Cat. 3; R63 Xn; R22 Xi; R38 R43 N; R51-53 F; Xn; N R: 11-22-38-43-63-51/53 S: (2-)7-22-33-36/37-61 612-252-00-4 imidacloprid (ISO); 1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine 428-040-8138261-41-3 Xn; R22 N; R50-53 Xn; N R: 22-50/53 S: (2-)22-57-60-61 612-253-00-X 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0,5 % formamide (EC No 200-842-0)] 429-400-7199327-61-2R52-53 R: R52/53 S: 61 612-253-01-7 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)] 429-400-7199327-61-2 Repr. Cat. 2; R61 R52-53 T R: 61-52/53 S: 53-45-61 612-254-00-5reaction products of diisopropanolamine with formaldehyde (1:4)432-440-8220444-73-5 Carc. Cat. 3; R40 Xn; R22 C; R34 R43 N; R51-53 C; N R: 22-34-40-43-51/53 S: (1/2-)13-25-26-36/37/39-45-61 612-255-00-01-(3-methoxypropyl)-4-piperidinamine431-950-8179474-79-4 Xn; R21/22 C; R34 R52-53 C R: 21/22-34-52/53 S: (1/2-)26-36/37/39-45-61 612-256-00-6benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate427-470-3137864-22-3 Xn; R22 R43 Xn R: 22-43 S: (2-)36/37 612-257-00-1tripropylammonium dihydrogenphosphate433-700-335687-90-2Xn; R22 Xn R: 22 S: (2-)22 612-259-00-2N-ethyl-3-trimethoxysilyl-2-methyl-propanamine437-720-3227085-51-0Xi; R41 Xi R: 41 S: (2-)26-39 612-261-00-33,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline441-190-9121451-05-6 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 C ≥ 25 %: Xn, N; R22-43-50/53 2,5 % ≤ C < 25 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 612-265-00-5bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate444-360-0191617-13-7R52-53 R: 52/53 S: 61 612-266-00-03-chloro-4-(3-fluorobenzyloxy)aniline445-590-4202197-26-0 Muta. Cat. 3; R68 Xn; R22-48/22 N; R50-53 Xn; N R: 22-48/22-68-50/53 S: (2-)22-36/37-60-61 612-267-00-6bis(hydrogenated tallow C16-18-alkyl)hydroxylamine418-370-0— R43 R53 Xi R: 43-53 S: (2-)36/37-61 612-269-00-7 mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole; mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline 420-720-2—R53 R: 53 S: 22-61 612-270-00-2(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride433-010-2— Xn; R22 R43 R52-53 Xn R: 22-43-52/53 S: (2-)22-36/37-61 612-271-00-8 mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate 434-970-5160987-57-5R53 R: 53 S: 61 612-272-00-3ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate435-210-5—N; R51-53

N R: 51/53 S: 61 612-273-00-9alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride435-650-8— Xn; R22 C; R35 N; R50-53 C; N R: 22-35-50/53 S: (1/2-)26-36/37/39-45-60-61 612-274-00-4(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate445-750-3— Xn; R22 Xi; R41 R43 R52-53 Xn R: 22-41-43-52/53 S: (2-)22-24-26-37/39-61 612-275-00-Xfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil447-880-6206565-89-1 Xi; R38-41 R43 N; R50-53 Xi; N R: 38-41-43-50/53 S: (2-)23-26-36/37/39-60-61 C ≥ 20 %: Xi, N; R38-41-43-50/53 10 % ≤ C < 20 %: Xi, N; R41-43-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 612-276-00-51-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts451-430-4500717-36-2 Xi; R41 R43 R52-53 Xi R: 41-43-52/53 S: (2-)22-24-26-36/37/39-61 612-277-00-0 mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium 451-440-9586372-44-3Xi; R41 Xi R: 41 S: (2-)22-26-39 612-278-00-6 ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide 214-984-61239-45-8 Muta. Cat. 3; R68 T+; R26 Xn; R22 T+ R: 22-26-68 S: (1/2-)28-36/37-45-63 612-279-00-1(R,S)-2-amino-3,3-dimethylbutane amide447-860-7144177-62-8 Repr. Cat. 3; R62 Xn; R48/22 Xi; R36/38 R43 Xn R: 36/38-43-48/22-62 S: (2-)22-26-36/37 612-280-00-7 3-amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine H205-057-7132-32-1Carc. Cat. 2; R45 T R: 45 S: 53-45 613-116-01-4 tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 211-986-9731-27-1 Xi; R36/37/38 R43 N; R50 Xi; N R: 36/37/38-43-50 S: (2-)25-36/37-46-61 C ≥ 20 %: Xi, N; R36/37/38-43-50 2,5 % ≤ C < 20 %: Xi, N; R43-50 1 % ≤ C < 2,5 %: Xi; R43 613-280-00-X tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea 230-625-67226-23-5 Repr. Cat. 3; R62 Xn; R22 Xi; R41 Xn R: 22-41-62 S: 26-36/37/39 613-281-00-5quinolineE202-051-691-22-5 Carc. Cat. 2; R45 Muta. Cat. 3; R68 Xn; R21/22 Xi; R36/38 N; R51-53 T; N R: 45-21/22-36/38-68-51/53 S: 53-45-61 613-282-00-0 triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol —131983-72-7N; R51-53 N R: 51/53 S: 61 613-283-00-6 ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone

E265-667-465277-42-1 Repr. Cat. 2; R60 T; R25 Xn; R48/22 N; R50-53 T; N R: 60-25-48/22-50/53 S: 53-45-60-61 613-284-00-1 metconazole (ISO); (1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol —125116-23-6 Repr. Cat. 3; R63 Xn; R22 N; R51-53 Xn; N R: 22-63-51/53 S: (2-)36/37-46-61 613-285-00-7 1-hydroxybenzotriazole, anhydrous; [1] 1-hydroxybenzotriazole, monohydrated [2] 219-989-7 [1] 219-989-7 [2] 2592-95-2 [1] 123333-53-9 [2] E; R2 E R: 2 S: 16-35 613-286-00-2 potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)] 418-260-2183196-57-8R43 Xi R: 43 S: (2-)24-37 613-286-01-X potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)] 418-260-2183196-57-8 Repr. Cat. 2; R61 R43 T R: 61-43 S: 53-45 613-287-00-81-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole419-540-7160194-26-3 Xn; R22 R43 N; R51-53 Xn; N R: 22-43-51/53 S: (2-)24-37-61 613-288-00-31,3-bis(dimethylcarbamoyl)-imidazolium chloride420-930-4135756-61-5 Xn; R22 Xi; R41 R52-53 Xn R: 22-41-52/53 S: (2-)22-26-37/39-61 613-289-00-93-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole432-020-4142623-48-1N; R50-53 N R: 50/53 S: 60-61 613-290-00-44-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride432-470-1189012-93-9 Xi; R41 R43 N; R50-53 Xi; N R: 41-43-50/53 S: (2-)24-26-37/39-60-61 613-291-00-X2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one434-820-9106461-41-0 Xn; R48/22 N; R50-53 Xn; N R: 48/22-50/53 S: (2-)22-36-60-61 613-292-00-5N,N′,N″-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine435-010-826157-73-3 Muta. Cat. 3; R68 R52-53 Xn R: 68-52/53 S: (2-)36/37-61 613-293-00-02-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester448-050-6444065-11-6R53 R: 53 S: 61 613-294-00-62-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester448-260-8379268-96-9R53 R: 53 S: 61 613-295-00-111-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride448-720-8363138-44-7 Xn; R22 Xi; R41 R52-53 Xn R: 22-41-52/53 S: (2-)22-26-39-61 613-296-00-7pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate418-270-7— R43 R52-53 Xi R: 43-52/53 S: (2-)24-37-47-61 613-297-00-25-(2-bromophenyl)-2-tert-butyl-2H-tetrazole420-820-6— R10 Xn; R22 N; R51-53 Xn; N R: 10-22-51/53 S: (2-)16-61 613-298-00-8bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate421-560-6—

Xn; R48/22 Xi; R41 N; R51-53 Xn; N R: 41-48/22-51/53 S: (2-)22-26-36/39-61 613-299-00-3 main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt 422-610-1—Xi; R41 Xi R: 41 S: (2-)22-26-39 613-300-00-71-imidazol-1-yl-octadecan-2-ol434-120-3— R43 R53 Xi R: 43-53 S: (2-)24-37-61 613-301-00-2dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate443-910-7—R53 R: 53 S: 61 613-302-00-8disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate432-980-4243858-60-8Xi; R41 Xi R: 41 S: (2-)22-26-39 613-303-00-32-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine429-800-195737-68-1N; R50-53 N R: 50/53 S: 60-61 613-304-00-95,6-dihydroxy-2,3-dihydro-1H-indolium bromide421-170-6138937-28-7 Xn; R22 Xi; R41 Xn R: 22-41 S: (2-)22-26-39 613-305-00-42-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole448-630-93147-77-1R53 R: 53 S: 61 613-306-00-X(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate433-520-582911-69-1 Xn; R22 R43 N; R51-53 Xn; N R: 22-43-51/53 S: (2-)24-37-61 613-307-00-5 clothianidin (ISO); 3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine —210880-92-5 Xn; R22 N; R50-53 Xn; N R: 22-50/53 S: (2-)46-60-61 C ≥ 25 %: Xn, N; R22-50/53 2,5 % ≤ C < 25 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 613-308-00-02-amino-5-methylthiazole423-800-57305-71-7 Xn; R22-48/22 N; R50-53 Xn; N R: 22-48/22-50/53 S: (2-)22-36-60-61 613-309-00-61-methyl-3-phenyl-1-piperazine431-180-25271-27-2 Xn; R21/22 Xi; R38-41 R52-53 Xn R: 21/22-38-41-52/53 S: (2-)26-36/37/39-61 613-310-00-1(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride432-360-3105813-13-6 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)22-24-37-60-61 613-311-00-7methyl-5-nitrophenyl-guanidine435-500-1152460-07-6 Xn; R22 Xi; R36 R43 R52-53 Xn R: 22-36-43-52/53 S: (2-)22-24-26-37-61 613-312-00-22-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride420-200-5— Xn; R22 Xi; R41 R43 R52-53 Xn R: 22-41-43-52/53 S: (2-)22-26-36/37/39-61 613-313-00-82-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione442-780-9173838-67-0R52-53

R: 52/53 S: 61 613-314-00-3 4-decyloxazolidin-2-one; 4-decyl-1,3-oxazolidin-2-one 443-770-77693-82-5N; R50-53 N R: 50/53 S: 22-24-60-61 613-315-00-9tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate430-390-1— Xn; R20 R52-53 Xn R: 20-52/53 S: (2-)25-61 613-316-00-4 trimethylopropane tri(3-aziridinylpropanoate); (TAZ) H257-765-052234-82-9 Muta. Cat. 3; R68 Xi; R41 R43 Xn R: 41-43-68 S: 26-36/37/39-42 615-044-00-14-chlorophenylisocyanate203-176-9104-12-1 T+; R26 Xn; R22 Xi; R37/38-41 R42 N; R50-53 T+; N R: 22-26-37/38-41-42-50/53 S: (1/2-)26-28-36/37/39-45-63-60-61 615-045-00-74,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)420-530-1— R42/43 R53 Xn R: 42/43-53 S: (2-)23-24-37-45-61 616-126-00-X1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide423-960-6139756-01-7 Xn; R22-48/22 R52-53 Xn R: 22-48/22-52/53 S: (2-)22-36/37-61 616-164-00-7 dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide —149961-52-4 Carc. Cat. 3; R40 Repr. Cat. 3; R63 Xn; R20 N; R50-53 Xn; N R: 20-40-63-50/53 S: (2-)36/37-46-60-61 C ≥ 25 %: Xn, N; R20-40-63-50/53 5 % ≤ C < 25 %: Xn, N; R40-63-50/53 2,5 % ≤ C < 5 %: Xn, N; R40-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52-53 616-165-00-2 beflubutamid (ISO); (RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide —113614-08-7N; R50-53 N R: 50/53 S: 60-61 C ≥ 0,25 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 616-166-00-8 cyazofamid (ISO); 4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide —120116-88-3N; R50-53 N R: 50/53 S: 60-61 C ≥ 2,5 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51-53 0,025 % ≤ C < 0,25 %: R52/53 616-167-00-3N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide418-290-6168612-06-4 Xi; R36 R43 Xi R: 36-43 S: (2-)24-26-37 616-168-00-91-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium418-440-0136997-71-2R43 Xi R: 43 S: (2-)22-24-37 616-169-00-44-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one420-220-492771-56-7 R43 R53 Xi R: 43-53 S: (2-)24-37-61 616-170-00-X(2R)-2-amino-2-phenylacetamide420-370-06485-67-2 Xi; R36 R43 Xi R: 36-43 S: (2-)22-26-36/37 616-171-00-52-(para-chlorophenyl)glycineamide420-830-0102333-75-5 Xi; R41 R43 Xi R: 41-43 S: (2-)24-26-37/39 616-172-00-0 N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide; (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl 423-840-314691-89-5Xn; R22 Xn R: 22 S: (2-)22 616-174-00-12-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride424-560-4151257-01-1 Xn; R22 Xi; R36 Xn R: 22-36 S: (2-)22-26 616-175-00-72-(2-hexyldecyloxy)benzamide431-230-3202483-62-3R53 R: 53 S: 61 616-176-00-23-N,N-bis(methoxyethyl)aminoacetanilide432-530-724294-01-7 Xn; R22 R52-53 Xn R: 22-52/53 S: (2-)22-24-61 616-177-00-8 (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;

N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide 432-970-1217324-98-6R53 R: 53 S: 61 616-178-00-3N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide434-500-952583-35-4R53 R: 53 S: 22-61 616-179-00-92-chloro-N-(4-methylphenyl)acetamide435-170-916634-82-5 Xi; R41 R43 N; R50-53 Xi; N R: 41-43-50/53 S: (2-)22-26-36/37/39-60-61 616-180-00-4N,N-(dimethylamino)thioacetamide hydrochloride435-470-127366-72-9 Repr. Cat. 2; R61 N; R50-53 T; N R: 61-50/53 S: 53-45-60-61 616-181-00-X4′-methyldodecane-1-sulfonanilide435-490-917417-32-2N; R50-53 N R: 50/53 S: 60-61 616-182-00-5N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide435-860-1214417-91-1 R43 N; R51-53 Xi; N R: 43-51/53 S: (2-)24-37-61 616-183-00-0N-dodecyl-4-methoxybenzamide442-340-61854-15-5R53 R: 53 S: 61 616-184-00-63-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide442-560-2105043-55-8R53 R: 53 S: 61 616-186-00-7N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)443-010-453641-10-4R52-53 R: 52/53 S: 61 616-188-00-82-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide443-980-9221215-20-9 R43 R53 Xi R: 43-53 S: (2-)24-37-61 616-189-00-3N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide444-780-4452962-97-9R53 R: 53 S: 61 616-190-00-9N-decyl-4-nitrobenzamide445-880-064026-19-3R53 R: 53 S: 61 616-191-00-42-ethyl-N-methyl-N-(3-methylphenyl)butanamide446-190-2406488-30-0 Xn; R22 Xi; R36/38 R43 N; R51-53 Xn; N R: 22-36/38-43-51/53 S: (2-)24-26-37-61 616-192-00-X2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide448-060-0727678-39-9R53 R: 53 S: 61 616-193-00-5N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide449-940-7368450-39-9R53 R: 53 S: 61 616-194-00-02,2-diethoxy-N,N-dimethylacetamide449-950-134640-92-1Xi; R36 Xi R: 36 S: (2-)26 616-196-00-1disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide419-990-4—N; R50-53 N R: 50/53 S: 60-61 616-197-00-7 mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide 422-500-1—Xn; R48/22 Xn R: 48/22 S: (2-)22-36 616-198-00-21,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene423-300-7— R43 R53 Xi R: 43-53 S: (2-)24-37-61 616-200-00-1 mixture of: N,N′-ethane-1,2-diylbis(hexanamide); 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide; N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide) 432-430-3— R43 R53 Xi R: 43-53 S: (2-)24-37-61 616-201-00-712-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine432-840-2220926-97-6

Xn; R20 R53 Xn R: 20-53 S: (2-)22-61 616-202-00-2 mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide 434-330-5— Carc. Cat. 3; R40 R43 R53 Xn R: 40-43-53 S: (2-)36/37-61 616-203-00-8 mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide; N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide 442-280-0—R53 R: 53 S: 61 616-204-00-3N,N″-(methylenedi-4,1-phenylene)bis[N′-octylurea]451-060-3122886-55-9R53 R: 53 S: 61 617-022-00-7 mixture of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate 442-480-8— O; R7 Xn; R22 C; R34 R43 N; R51-53 O; C; N R: 7-22-34-43-51/53 S: (1/2-)3/7-14-26-36/37/39-45-50-61 647-017-00-5laccase420-150-480498-15-3R42 Xn R: 42 S: (2-)23-45

Annex

ANNEX 1C The entries in Annex I with the following Index numbers are deleted: 024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.